fbpx
The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

For the fourth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the six best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB. The DCB Innovation Challenge is the world’s largest diabetes technology award with international appeal.

Can Your Idea Change Diabetes Management?

More than 537 million people worldwide live with diabetes, which means a constant challenge in everyday life for those affected. Technological innovations make an important contribution to making it easier to deal with diabetes – whether it is measuring glucose levels, planning the amount of insulin needed via an app or even using automated insulin delivery systems. But despite these enormous advances in diabetes technology, there is still a great, unmet need for innovative technical solutions. These should help to ease the challenge for users in everyday life and improve the lives of people with diabetes in the long term.

The DCB Open Innovation Challenge was initiated in 2021 with the aim of closing these gaps in diabetes technology with translational research. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable to us. We’re seeking diverse perspectives and innovative solutions to enhance the quality of life for individuals with diabetes.

 

What’s in it for you?

After a first round and feedback from the expert jury, the top 20 will enter a mentoring program. Two US-based innovators and four innovators from the rest of the world will be invited to an individually tailored bootcamp in the picturesque Swiss alps and will then pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​

The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support – making the DCB Open Innovation Challenge the world’s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field – all while your idea remains entirely yours.

Don’t miss out on this unparalleled opportunity to turn your idea into reality. Submit your idea by April 30 at our innovation platform innovation.dcberne.com

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

The newly created assistant professorship with tenure track is the third of a total of three professorships in the field of “Diabetes Technology and Artificial Pancreas” jointly created by the University of Bern, the Inselgruppe and the Diabetes Center Berne (DCB).

Background in developing data science products for medical devices

Before taking up her new position, Lisa Koch worked on machine learning for biomedical data analysis. She has a background in academic research as well as developing data science products for medical devices, with a strong focus on technology that can ultimately benefit people’s health in a safe and trustworthy way.

After an undergraduate degree in electrical (BSc) and biomedical engineering (MSc) at ETH Zürich, Switzerland, Lisa Koch did a PhD in machine learning for medical image analysis at Imperial College London, UK.  After a post-doc at ETH Zürich, she joined the Swiss wearable medical device startup Ava, where she eventually became the data science team lead. In this position, she came to appreciate the need for demonstrably safe machine learning in healthcare.

Safe, reliable, and effective data science tools
In 2021, Lisa Koch returned to academic research to pursue research on this topic as a group leader for machine learning in medical diagnostics at the Hertie Institute for AI in Brain Health at the University of Tübingen, Germany. In her new role as assistant professor at the University of Bern, her long-term goal is to develop certifiably safe, reliable, and effective data science tools for patient-specific treatment systems in diabetes care.

“With my research, I strive to deliver trustworthy AI-enabled diabetes care that provides real benefit to patients and clinicians. I am thrilled to join the cross-disciplinary ecosystem at the Diabetes Center Berne and the University of Bern Clinic for Diabetology, Endocrinology, Nutritional Medicine and Metabolism (UDEM), an ideal environment to advance this vision” says Koch.

Derek Brandt, CEO of the DCB adds: “In addition to Lilian Witthauer, professor in the field of sensor technology, and José Garcia Tirado, professor for technology-assisted precision medicine, we have taken a third and important step with Professor Koch for the topic of artificial intelligence (AI) and data science in diabetes care. This enables us to further strengthen our international pioneering role in the field of translational diabetes technology research. We will continue doing everything we can to improve daily life for people with diabetes”.

Lisa Koch

Downloads

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

We are very excited to announce the launch of the 2024 DCB Open Innovation Challenge for 1 April 2024, this year in collaboration with the Diabetes Technology Society!

Can Your Idea Change Diabetes Management Forever?

We are excited to announce the collaboration of the Diabetes Center Berne and the Diabetes Technology Society for the 2024 DCB Open Innovation Challenge, launching on 1 April 2024.​

The DCB Open Innovation Challenge was initiated in 2021 and is the largest innovation challenge in the field of diabetes technology. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Anyone with an idea can apply – whether researcher, healthcare professional, start-up or person living with diabetes. We want to hear from you!​

In 2024, two US-based innovators and four innovators from the rest of the world will be selected to pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​ ​

Save the dates and seize the opportunity to watch your idea become reality: www.dcberne.com/en/innovation-challenge

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

Bern, 4 March 2024 – Yesterday was the 85th anniversary of Switzerland’s oldest Disease Awareness Day, the “Day of the Sick”. The aim is to raise public awareness of health and disease issues. The President of the Swiss Confederation gives a speech at this event, which this year was held at the Diabetes Centre Berne (DCB).

“Strengthening confidence” is the motto of this year’s “Day of the Sick”. In connection with this and as a strong player in innovation and research in the field of diabetes technology, the Diabetes Center Berne had the honour of hosting this year’s speech by the President of the Swiss Confederation, Viola Amherd. Supplemented by two statements from the DCB, from the perspective of people with diabetes, the President addressed the influence of collaboration and innovative technologies as well as the situation of carers and patients. 

“I had to prick my finger around 60,000 times to measure my blood sugar level. You can still see the traces of this on my fingertips today. Now I have a sensor on my arm that continuously measures my blood glucose level. This technological innovation has not only given me back valuable time, but also a lot of quality of life,” summarises Maren Schinz, Innovation Manager at the DCB, who has type I diabetes. 

The CEO of the DCB, Derek Brandt, adds: “Here at the Diabetes Centre Berne, we exchange ideas and develop new technologies. Our aim is to use new approaches to give people with diabetes back their freedom so that other areas of their lives can be given more space again.” 

Watch the recording now:

About DCB 
The Diabetes Center Berne (DCB) is a private, independent Swiss foundation established in 2017 with the aim of making life with diabetes easier. DCB supports ideas and projects in the field of diabetes technology worldwide by providing expertise, access to clinical research facilities and its own laboratories as well as financial resources. The aim is to work in partnership to bring them a big step closer to market entry. The work of the DCB is not profit-orientated – the goal is new findings and innovations in diabetes management as well as a lively community. 

 

About “Day of the Sick” 
The “Day of the Sick” is a non-profit organisation that was founded in 1939. Its members include patient organisations as well as health leagues, industry and professional associations, the Swiss Conference of Cantonal Health Directors (GDK) and other associations and federations active in the healthcare sector.  
Once a year, the “Day of the Sick” sensitises the population to a special topic in the area of health and illness. It aims to help promote relationships between the sick and the healthy, create understanding for the needs of the sick and remind people of the duties of the healthy towards the sick. It is also committed to recognising the activities of all those who work professionally and privately on behalf of patients and the sick. 

Media Contacts

Diabetes Center Berne

 

Freiburgstrasse 3
CH-3010 Berne
www.dcberne.com

Media Contact

Sunjoy Mathieu
sunjoy.mathieu@dcberne.com

Office Day of the Sick

c/o Nicole Fivaz
Hangweg 22
CH-3125 Toffen
www.tagderkranken.ch

Media Contact

Nicole Fivaz
info@tagderkranken.ch

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

Berlin, February 13, 2024 – The Una Health smartphone app for diabetes, a digital application for the treatment of type 2 diabetes, has been included in the DiGA directory by the Federal Institute for Drugs and Medical Devices (BfArM) in Germany as a digital health application (DiGA) and can now be prescribed on prescription. Una Health for Diabetes is the first German DiGA with a holistic and personalized treatment approach that combines blood glucose monitoring, lifestyle, drug treatment and mental health.

Una Health approved as German Digital Health Application (DiGA) for diabetes: New guideline-based solution for type 2 diabetes

In 2022, Una Health won the DCB Open Innovation Challenge in the Digital Diabetes category. Now, they have achieved a major milestone: the app for managing type 2 diabetes has now been qualified as a DiGA (German Digital Health Application) and can now be prescribed on prescription in Germany.

Type 2 diabetes affects almost 9 million people in Germany, and the trend is rising. The disease requires continuous monitoring and blood glucose control in order to avoid concomitant diseases such as renal insufficiency or retinal damage and a negative course of the disease. The approval of Una Health for diabetes has now made it possible to offer a non-drug therapy option to improve the quality of life for people living with type 2 diabetes. The application combines continuous glucose meter and dietary data in a mobile app that helps people with type 2 diabetes understand the reasons for their blood glucose fluctuations and make long-term lifestyle changes to keep their glucose levels stable. The therapy is available for all people with a diabetestype 2 diagnosis from the age of 18 (ICD 10 E11.-).

Function and evidence

By analysing individual blood glucose reactions, the app offers personalised lifestyle recommendations that improve blood glucose control. With evidence-based content, goal functions and coaching messages, the app facilitates effective implementation of lifestyle changes. This innovative approach enables users to expand their knowledge about diabetes and optimise their lifestyle in a personalized way. In a clinical study in collaboration with Prof. Dr. med. Peter Schwarz, diabetologist at the TU Dresden and President of the International Diabetes Federation (IDF), it was shown that the use of Una Health for Diabetes led to a significant improvement in blood glucose levels, weight and quality of life in people with type 2 diabetes. 96% of users would recommend the application to others.

Development

“We are thrilled to introduce Una Health for Diabetes to the public after an intensive development phase. Our non-drug treatment approach is helping to improve the care and quality of life for people with type 2 diabetes,” says Matthew Fenech, MD, diabetologist and founder of Una Health. “Our mission is to combine innovative technology with medical expertise to create solutions for the millions of people with diabetes and caregivers that are both easily accessible and easy to integrate into everyday life. We want to empower people to take a proactive approach to their health and better understand the impact of lifestyle and behavior.”

Una Health for Diabetes was developed with leading diabetologists and nutritionists to high clinical and data protection standards in Germany. Professor Martin Möckel, MD, internist and Medical Director of Emergency and Acute Medicine at Charité Berlin and Chairman of the “Digital Health Applications/AI in Guidelines” working group at the German Society of Internal Medicine (DGIM), confirms: “Una Health GmbH has developed a program that has a lasting impact on patients’ lifestyles and motivates them to change their behaviour by directly reflecting back to them”. Una Health for Diabetes 2023 impressed the expert jury of the DiGA Pitch Battle at the DGIM congress in Wiesbaden with its sustainable concept.

 

The application is now available for Android and iOS devices. To find out more about use and prescription, visit the website at https://unahealth.de/for-partners.

 

About Una Health:

The start-up Una Health won the DCB Open Innovation Challenge in the Digital Diabetes category in 2022. Una Health, based in Germany, is a leading provider of digital health applications with a mission to address the ever-growing burden of metabolic disease. By providing personalised tools and resources, Una Health helps users to manage their blood glucose levels, adapt their lifestyle and develop healthier habits in the long term. The mission is to combine innovative technology with medical expertise to provide personalised solutions that enable people to proactively address their health and lead a fulfilling life.

Links

Contact

Press department Una Health

E-Mail: presse@unahealth.de

Phone: +49 – 30 – 863 232 552

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Diabetes Center Berne and Tidepool: New Collaboration to Advance Research in Diabetes and Women’s Health

Diabetes Center Berne and Tidepool: New Collaboration to Advance Research in Diabetes and Women’s Health

Diabetes Center Berne and Tidepool: New Collaboration to Advance Research in Diabetes and Women’s Health

Bern/Palo Alto, 13 December 2023 – Diabetes Center Berne (DCB), a private, independent Swiss foundation and Tidepool, a US-based non-profit organisation are entering a partnership to explore the relationship between diabetes and women’s health. The first initiative in this collaboration will focus on the menstrual cycle’s influence on insulin-dependent diabetes.

Menstrual Cycle Study

Recognizing the challenges faced by women with insulin-dependent diabetes, research specifically investigating the menstrual cycle’s impact on diabetes management remains limited so far. This lack of focused study has hindered the development of tailored treatment strategies for women. The partnership between Diabetes Center Berne (DCB) and Tidepool aims to fill this critical research gap. Their joint effort is focused on the examination of the interplay between the menstrual cycle and diabetes management, with the goal of enhancing care and improving quality of life.

To explore the relationship between menstrual cycles and insulin-dependent diabetes with the goal of supporting the development of tools and products to lower the burden of diabetes management throughout the menstrual cycle, Tidepool and DCB are joining forces and will start with a first study. Tidepool facilitates access to the data of people living with type 1 diabetes who menstruate and provides their expertise in data collection for this initiative and DCB will provide expertise in clinical research and research infrastructure.

“Tidepool and DCB share common goals,” says Martina Rothenbühler, Data Science Lead at DCB. “We are both non-profit organizations aiming to make life with diabetes easier, fostering innovation, and sharing a deep interest in translating scientific findings into recommendations and tools that make diabetes management easier.”

Stefanie Hossmann, Clinical Research Lead at DCB, adds: “Partnering with Tidepool offers us an opportunity to meet with a highly motivated team dedicated to analyzing different aspects around the menstrual cycle, the Tidepool Period Project.”

“The DCB team has a strong academic focus that complements the roadmap we have built out for the Tidepool Period Project and the skills that we have on the Tidepool team, and we are so excited about this partnership,” said Saira Khan-Gallo, Access & Equity lead at Tidepool. 

About DCB
Diabetes Center Berne (DCB) is a private, independent Swiss foundation established in 2017 with the aim of making life with diabetes easier. DCB supports ideas and projects in the field of diabetes technology worldwide by providing expertise, access to clinical research facilities and its own laboratories, as well as financial resources. The aim is to bring them a big step closer to market entry in a collaborative partnership. The work of the DCB is non-profit – the goal is new insights and innovations around diabetes management as well as a vibrant community.

About Tidepool
Tidepool is a recognized innovator in diabetes software on a mission to make diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers. Founded in 2013, Tidepool hosts a suite of software tools for people with diabetes and the clinics that serve them, including Tidepool Web, Tidepool Mobile, Tidepool Uploader, and soon Tidepool Loop. Tidepool is a registered 501(c)3 nonprofit organization. Learn more at tidepool.org. Follow us on Twitter at @Tidepool_org and on Facebook and Instagram.

Contacts

Diabetes Center Berne

Fribourgstrasse 3
CH-3010 Berne 
www.dcberne.com

Media Contact
Sunjoy Mathieu
medien@dcberne.com

Tidepool

555 Bryant Street #429
Palo Alto, CA 94301
www.tidepool.org

Media Contact
Saira Khan-Gallo
media@tidepool.org

Links

About the Menstrual Cycle Study

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland